INVESTOR ALERT: Pomerantz Law Firm Investigates Claims - On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX

  • NEW YORK CITY, NY / ACCESS Newswire / April 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Pliant Therapeutics, Inc ("Pliant" or the "Company") (NASDAQLRX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com  or 646-581-9980, ext.